Circumscribed Morphea Successfully Treated With Excimer Laser: Analysis of Histopathological Changes
The Journal of Dermatology · 2026-04 · 53 (4) · 691-695
DOI: 10.1111/1346-8138.70225 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Dermatology, online erschienen am 18.03.2026. Verfasst von Takuya Takahashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Scleroderma, Localized, Lasers, Excimer, Skin, Low-Level Light Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Localized scleroderma (LSc) is an autoimmune condition characterized by localized cutaneous sclerosis, sometimes extending into deeper tissues. Phototherapy, including excimer laser therapy (ELT), is considered an effective and minimally invasive treatment option for patients without extracutaneous involvement. However, little is known about the histopathological and molecular alterations that occur during treatment. Here, we report a case of circumscribed morphea successfully treated with ELT, accompanied by detailed longitudinal histological analysis. A 78‐year‐old woman presented with gradually progressive indurated plaques on both sides of the abdomen. Histopathological examination of the lesional skin revealed dense collagen deposition and perivascular infiltration of lymphocytes, monocytes, and mast cells, confirming the diagnosis of circumscribed morphea. Topical glucocorticoid therapy yielded insufficient improvement, prompting the addition of 308‐nm ELT. The patient underwent 12 ELT sessions, administered every two to four weeks with incremental dosing from 100 mJ/cm 2 to 240 mJ/cm 2 , reaching a cumulative dose of 2100 mJ/cm 2 . This regimen resulted in marked clinical improvement within one year. Post‐treatment biopsies demonstrated near‐complete resolution of dermal sclerosis, with substantial reductions in inflammatory cell infiltration. Toluidine blue staining and immunohistochemistry further revealed dynamic cellular changes: mast cells and CD3 + T cells were significantly decreased; CD34 expression, absent in lesional dermal mesenchymal cells before treatment, was restored; and α‐smooth muscle actin‐positive myofibroblasts, abundant at baseline, were markedly reduced following ELT. These findings indicate that ELT not only ameliorates clinical sclerosis but also reverses immune and mesenchymal cell alterations associated with fibrosis. This case highlights the therapeutic potential of ELT in circumscribed morphea and suggests a plausible mechanism by which ELT modulates immune–mesenchymal interactions to attenuate fibrosis in LSc.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID-Profile: Takuya Takahashi, Takehiro Takahashi, Toshiya Takahashi, Yoshihide Asano
Zitieren
APA
Takahashi, T., Takahashi, T., Segawa, Y., Oka, K., Takahashi, T., & Asano, Y. (2026). Circumscribed Morphea Successfully Treated With Excimer Laser: Analysis of Histopathological Changes. The Journal of Dermatology, 53(4), 691-695. https://doi.org/10.1111/1346-8138.70225
Vancouver
Takahashi T, Takahashi T, Segawa Y, Oka K, Takahashi T, Asano Y. Circumscribed Morphea Successfully Treated With Excimer Laser: Analysis of Histopathological Changes. The Journal of Dermatology. 2026;53(4):691-695. doi:10.1111/1346-8138.70225
BibTeX
@article{Takahashi2026,
author = {Takahashi, Takuya and Takahashi, Takehiro and Segawa, Yuichiro and Oka, Kenta and Takahashi, Toshiya and Asano, Yoshihide},
title = {Circumscribed Morphea Successfully Treated With Excimer Laser: Analysis of Histopathological Changes},
journal = {The Journal of Dermatology},
year = {2026},
volume = {53},
number = {4},
pages = {691--695},
doi = {10.1111/1346-8138.70225}
}
EUVIMED